CVRdatabase
Menu

Sophion Bioscience A/S

Public limited companyCVR 10021065BallerupActive

Sophion Bioscience A/S is a public limited company, based in Ballerup, active in research and experimental development on natural sciences and engineering, founded in 2000. Net profit fell 89% from 2024 to 2025, ending at DKK 4.4m. With 90 employees, the company is about 18 times larger than the industry median. Gross profit is higher than that of 96% of the companies in the industry in the database.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 102.1m−14.6% vs. 2024
Net profitDKK 4.4m−88.9% vs. 2024
EquityDKK 178.4m−7.1% vs. 2024
Employees90latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 15% (2024 → 2025), to DKK 102.1m.
  • Net profit fell 89% (2024 → 2025), to DKK 4.4m.
  • Equity fell 7% (2024 → 2025), to DKK 178.4m.

Employees

  • 1 fewer employees than a year earlier: 90 (08/2026) against 91 (08/2025).

Management and owners, last 24 months

  • New in management: Gustaf Peter Reinhold von Ehrenheim (board member, 03/12/2025) and Harald Høegh (chair of the board, 03/12/2025).
  • Stepped down: Gustaf Peter Reinhold von Ehrenheim (chair of the board, 02/12/2025) and Harald Høegh (board member, 02/12/2025).

Registrations, last 24 months

  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 20mDKK 40mDKK 60mDKK 80mDKK 100mDKK 120mDKK 140mDKK 160mDKK 180mDKK 200m202020212022202320242025
EquityNet profit
Financial figures for Sophion Bioscience A/S
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit77,48498,346117,686113119,621102,112−14.6%
Operating profit (EBIT)31,53744,96953,02639,27346,6137,640−83.6%
Profit before tax31,98645,17955,80536,01249,3375,218−89.4%
Net profit25,21736,32444,36928,02239,1274,354−88.9%
Total assets140,116174,724222,631201,723246,788237,559−3.7%
Equity106,465143,846188,146156,953191,970178,418−7.1%
Liabilities33,65130,25428,83334,71737,52541,159+9.7%
Cash and cash equivalents24,00128,09130,24837,90836,5185,360−85.3%
Average number of employees354148577197+36.6%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 20mDKK 40mDKK 60mDKK 80mDKK 100mDKK 120m202020212022202320242025
Gross profitMedian, the industry (431 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Profit for five years in a row

    Net result has been positive in 2021–2025.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Sophion Bioscience A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202520/05/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202408/05/2025The companyPDF not statedXBRL
202301/01/2023 – 31/12/202331/05/2024The companyPDFXBRL
202201/01/2022 – 31/12/202203/04/2023The companyPDFXBRL
202101/01/2021 – 31/12/202101/03/2022The companyPDFXBRL
202001/01/2020 – 31/12/202022/02/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
02040608010009/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profitDKK 102.1mNo. 19 of 421
Better than 96% of the companies in the industry
EquityDKK 178.4mNo. 22 of 431
Better than 95% of the companies in the industry
Number of employees90No. 21 of 431
Better than 95% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bnHere
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 50–199 employees4,467 companies in the comparison
No. 636of 4,412
Better than 86%
No. 382of 4,466
Better than 91%
Same industry and 50–199 employees27 companies in the comparison
No. 7of 26
Better than 76%
No. 6of 27
Better than 81%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 704of 24,791
Better than 97%
No. 862of 24,909
Better than 97%
All companies of type A/S18,025 companies in the comparison
No. 1,537of 17,786
Better than 91%
No. 1,558of 18,024
Better than 91%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Sophion Bioscience A/SDKK 102.1m
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Sophion Bioscience A/SDKK 4.4m
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Sophion Bioscience A/SDKK 178.4m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Sophion Bioscience A/S90
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Sapphire Bioscience Holding ApS100%
Sophion Bioscience A/S

Management

6 active registrations

Executive management

Executive management at Sophion Bioscience A/S
NameRoleAppointed
Michel Krall JürgensCEO01/09/2024

Board of directors

Board of directors at Sophion Bioscience A/S
NameRoleAppointed
Thais Taaning JohansenBoard member27/12/2016
Peter MaxBoard member12/12/2017
Eirik LaugloBoard member08/02/2021
Gustaf Peter Reinhold von EhrenheimBoard member03/12/2025
Harald HøeghChair of the board03/12/2025
Founders
KR 332 ApS
Former management (44)
Former management at Sophion Bioscience A/S
NameRoleAppointedResigned
Michael Egede BudtzBoard member07/02/200014/03/2000
Erik Mohr MersingBoard member07/02/200014/03/2000
Anders Bjerre LavesenBoard member07/02/200014/03/2000
Jørgen ByrielDirector07/02/200014/03/2000
Steen Helde HemmingsenBoard member07/02/200022/05/2006
Arne GillinBoard member07/02/200023/05/2001
Henrik Kristian MoltkeBoard member14/03/200006/07/2000
Jørgen Buus LassenChair of the board14/03/200006/07/2000
Morten BechDirector14/03/200001/10/2004
Søren-Peter OlesenBoard member14/03/200018/08/2011
Torsten FreltoftCEO01/07/200016/08/2013
Jørgen DrejerBoard member06/07/200024/01/2001
Stephen Richard BiggarBoard member24/01/200109/09/2004
Felix James BakerBoard member24/01/200130/04/2003
Julian Charles BakerBoard member24/01/200130/04/2003
Mette Kirstine AggerBoard member30/04/200329/04/2005
Flemming PedersenChair of the board30/04/200314/09/2010
John Mountjoy ArnbergBoard member29/04/200518/08/2011
Mads VighBoard member22/05/200611/06/2007
Gudmund Tyge KorsgaardBoard member22/05/200618/08/2011
Jonas FrickBoard member22/05/200704/09/2007
Peter Bent Svejgaard KristensenBoard member27/08/200726/03/2009
Martin OlinBoard member17/09/200730/05/2008
Henrik LawaetzBoard member30/05/200818/08/2011
Renée Aguiar-LucanderBoard member25/05/200918/08/2011
Patrik Olof DahlénChair of the board14/09/201018/08/2011
Torsten FreltoftBoard member18/08/201116/08/2013
Bengt Jonas KasemoBoard member18/08/201127/10/2011
Jan Tomas WahlströmChair of the board18/08/201101/02/2013
Maria Elisabeth AnderssonBoard member18/08/201101/02/2013
Hans Sven Ragnar AugustinssonBoard member18/08/201127/10/2011
Anna Christina RubenhagBoard member01/02/201302/03/2016
Johan Olof Tade von HeineChair of the board01/02/201301/02/2013
Johan Olof Tade von HeijneChair of the board01/02/201303/03/2016
Morten SunesenBoard member16/08/201313/07/2015
Morten SunesenCEO16/08/201306/07/2015
Carsten Kronsbjerg FaltumCEO06/07/201527/12/2016
Carsten Kronsbjerg FaltumBoard member13/07/201527/12/2016
Anna Christina RubenhagChair of the board03/03/201616/02/2017
Maria Elisabeth AnderssonBoard member03/03/201616/02/2017
Thais Taaning JohansenCEO27/12/201631/08/2024
Jeanne EintoftBoard member16/02/201712/12/2017
Gustaf Peter Reinhold von EhrenheimChair of the board16/02/201702/12/2025
Harald HøeghBoard member08/02/202102/12/2025

Signing rule: Selskabet tegnes af den samlede bestyrelse eller af to af bestyrelsens medlemmer i forening eller af et bestyrelsesmedlem i fællesskab med en direktør

Address and production units

1 active production units

Industriparken 39
2750 Ballerup

Ballerup Municipality · Postcode 2750

Other companies at the address (5)

Production units
Production unitAddressEmployeesP number
SOPHION BIOSCIENCE A/SIndustriparken 39, 2750 Ballerup901007443354

Purpose

Selskabets formål er at drive forskning, handel, fabrikation og dermed beslægtet virksomhed primært inden for medicinalbranchen

The purpose is quoted from the register in Danish.

Changes year by year

124 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20256 changesmanagement 4 · accounts 1 · industry 1
  • Harald Høegh appointed chair of the board
  • Gustaf Peter Reinhold von Ehrenheim appointed board member
  • Harald Høegh stepped down as board member
  • Gustaf Peter Reinhold von Ehrenheim stepped down as chair of the board
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20244 changesmanagement 2 · accounts 1 · address 1
  • Michel Krall Jürgens appointed ceo
  • Thais Taaning Johansen stepped down as ceo
  • Annual report for 2023 published
  • Moved to Industriparken 39, 2750 Ballerup
20233 changesaddress 2 · accounts 1
  • Moved to Baltorpvej 154, 2750 Ballerup
  • Annual report for 2022 published
  • Moved to Baltorpvej 154, 2750 Ballerup
20221 changeaccounts 1
  • Annual report for 2021 published
20213 changesaccounts 1 · management 2
  • Annual report for 2020 published
  • Harald Høegh appointed board member
  • Eirik Lauglo appointed board member
20179 changesmanagement 6 · ownership 2 · capital 1
  • Peter Max appointed board member
  • Jeanne Eintoft stepped down as board member
  • Sapphire Bioscience Holding ApS registered as owner (100%)
  • Sophion Holding AB is no longer registered as owner
  • Share capital changed from 135,444,113 DKK to 50,000,000 DKK
  • Jeanne Eintoft appointed board member
  • Gustaf Peter Reinhold von Ehrenheim appointed chair of the board
  • Maria Elisabeth Andersson stepped down as board member
  • Anna Christina Rubenhag stepped down as chair of the board
20168 changesmanagement 8
  • Thais Taaning Johansen appointed ceo
  • Thais Taaning Johansen appointed board member
  • Carsten Kronsbjerg Faltum stepped down as board member
  • Carsten Kronsbjerg Faltum stepped down as ceo
  • Maria Elisabeth Andersson appointed board member
  • Anna Christina Rubenhag appointed chair of the board
  • Johan Olof Tade von Heijne stepped down as chair of the board
  • Anna Christina Rubenhag stepped down as board member
20154 changesmanagement 4
  • Carsten Kronsbjerg Faltum appointed board member
  • Morten Sunesen stepped down as board member
  • Carsten Kronsbjerg Faltum appointed ceo
  • Morten Sunesen stepped down as ceo
201310 changesmanagement 10
  • Morten Sunesen appointed ceo
  • Morten Sunesen appointed board member
  • Torsten Freltoft stepped down as board member
  • Torsten Freltoft stepped down as ceo
  • Johan Olof Tade von Heine appointed chair of the board
  • Johan Olof Tade von Heine stepped down as chair of the board
  • Johan Olof Tade von Heijne appointed chair of the board
  • Anna Christina Rubenhag appointed board member
  • Maria Elisabeth Andersson stepped down as board member
  • Jan Tomas Wahlström stepped down as chair of the board
20121 changeownership 1
  • Sophion Holding AB registered as owner (100%)
201113 changesmanagement 13
  • Bengt Jonas Kasemo stepped down as board member
  • Hans Sven Ragnar Augustinsson stepped down as board member
  • Bengt Jonas Kasemo appointed board member
  • Hans Sven Ragnar Augustinsson appointed board member
  • Maria Elisabeth Andersson appointed board member
  • Jan Tomas Wahlström appointed chair of the board
  • Torsten Freltoft appointed board member
  • Patrik Olof Dahlén stepped down as chair of the board
  • Renée Aguiar-Lucander stepped down as board member
  • Henrik Lawaetz stepped down as board member
  • Gudmund Tyge Korsgaard stepped down as board member
  • John Mountjoy Arnberg stepped down as board member
  • Søren-Peter Olesen stepped down as board member
20102 changesmanagement 2
  • Patrik Olof Dahlén appointed chair of the board
  • Flemming Pedersen stepped down as chair of the board
20092 changesmanagement 2
  • Renée Aguiar-Lucander appointed board member
  • Peter Bent Svejgaard Kristensen stepped down as board member
20085 changescapital 2 · management 2 · industry 1
  • Share capital changed from 129,161,490 DKK to 135,444,113 DKK
  • Henrik Lawaetz appointed board member
  • Martin Olin stepped down as board member
  • Share capital changed from 120,582,875 DKK to 129,161,490 DKK
  • Industry changed to Forskning og eksperimentel udvikling indenfor bioteknologi (721100)
20076 changesmanagement 5 · capital 1
  • Martin Olin appointed board member
  • Jonas Frick stepped down as board member
  • Peter Bent Svejgaard Kristensen appointed board member
  • Mads Vigh stepped down as board member
  • Jonas Frick appointed board member
  • Share capital changed from 103,245,357 DKK to 120,582,875 DKK
20063 changesmanagement 3
  • Mads Vigh appointed board member
  • Gudmund Tyge Korsgaard appointed board member
  • Steen Helde Hemmingsen stepped down as board member
20053 changescapital 1 · management 2
  • Share capital changed from 82,921,246 DKK to 103,245,357 DKK
  • John Mountjoy Arnberg appointed board member
  • Mette Kirstine Agger stepped down as board member
20043 changesmanagement 2 · capital 1
  • Morten Bech stepped down as director
  • Stephen Richard Biggar stepped down as board member
  • Share capital changed from 59,283,990 DKK to 82,921,246 DKK
20037 changescapital 2 · management 4 · address 1
  • Share capital changed from 58,444,030 DKK to 59,283,990 DKK
  • Flemming Pedersen appointed chair of the board
  • Mette Kirstine Agger appointed board member
  • Felix James Baker stepped down as board member
  • Julian Charles Baker stepped down as board member
  • Share capital changed from 31,584,030 DKK to 58,444,030 DKK
  • Moved to Baltorpvej 154, 2750 Ballerup
20015 changesmanagement 5
  • Arne Gillin stepped down as board member
  • Felix James Baker appointed board member
  • Julian Charles Baker appointed board member
  • Stephen Richard Biggar appointed board member
  • Jørgen Drejer stepped down as board member
200025 changescapital 2 · management 18 · name 2 · industry 1 · address 1 · founded 1
  • Share capital changed from 9,500,000 DKK to 31,584,030 DKK
  • Jørgen Drejer appointed board member
  • Jørgen Buus Lassen stepped down as chair of the board
  • Henrik Kristian Moltke stepped down as board member
  • Share capital changed from 500,000 DKK to 9,500,000 DKK
  • Torsten Freltoft appointed ceo
  • Name changed from IONS A/S to SOPHION BIOSCIENCE A/S
  • Industry changed to Forskning og udvikling inden for naturvidenskab og teknik (731000)
  • Name changed from KR 228 A/S to IONS A/S
  • Moved to Pederstrupvej 93, 2750 Ballerup
  • Jørgen Buus Lassen appointed chair of the board
  • Søren-Peter Olesen appointed board member
  • Morten Bech appointed director
  • Henrik Kristian Moltke appointed board member
  • Erik Mohr Mersing stepped down as board member
  • Jørgen Byriel stepped down as director
  • Anders Bjerre Lavesen stepped down as board member
  • Michael Egede Budtz stepped down as board member
  • Registered as KR 228 A/S
  • Erik Mohr Mersing appointed board member
  • Arne Gillin appointed board member
  • Steen Helde Hemmingsen appointed board member
  • Jørgen Byriel appointed director
  • Anders Bjerre Lavesen appointed board member
  • Michael Egede Budtz appointed board member

Related companies

Same industry in Ballerup

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction